Table 4: Comparison of study results versus other published studies.*

Present Study Wilson
2012 [30] 		Garcia 2016 [8] Rodriguez Diaz 2016 [8] RAPID/
LATAM 2010 [31] 		RAPID/
Peru 2010 [31] 		Muyanja 2016 [22] Divala 2016 [17] Esser 2013 [7] Hasse 2010
[11]		 CARMELA
2008 [61] 		HCH/SOL
2012 [62]
HIV status Positive Positive Positive Positive Positive Positive Positive Positive Positive Positive Negative Negative (men)
Setting Lima – Callao, Peru Santiago, Chile Basque Country, Spain Puerto Rico South America Lima, Peru Mbarara, Uganda Zomba, Malawi Leipzig, Germany Switzerland Major cities in LATAM Hispanics USA
Sample size (n) 305 121 224 250 4010 417 250 952 803 8444 11550 15079
Mean Age, years 46.0 46 48.8 47.9 41.9 39.1 36 43 44.2 45 NR NR
Male (%) 73.1 76.8 74.6 71.6 73.9 70.7 32 28.3 83.4 70.8 NR NR
Median time on HAART, years 7.78 10 NR 3.4 2.91 1.5 2.6 4 NR 6.4 N/A N/A
% VL < 50 90.8 85.2 93.3 NR NR NR NR NR 78.2 81 NR NR
Mean CD4 count 614.2 602 605 723.8 417 255 466 NR 461 528 N/A N/A
Dyslipidemia (%) 51.5 39.6 37.9 60.8 80.2 67.9 NR 28.7 ↑Tg, 15.5 ↑Chol 64.3 NR 14 52
Obesity (%) 11.1 NR 8.5 19.2 7.9 6.5 12 3.8 NR NR 23 37
Diabetes mellitus (%) 7.2 4.1 21.9 19.6 3.3 1.7 NR 4.1 5.1 4.1 7 17
Hypertension (%) 8.85 4.95 21.9 39.6 31.5 14.6 5.2 23.7 21 56.3 18 25
Other (%) Renal impairment 6.2 --- Hep C 51.3 EtOH abuse 48.8 --- --- --- --- CVD 10.1 Hep C 22.7 --- ---
Metabolic syndrome (%) NR NR NR NR 20.2 13.7 23.2 NR NR NR 20 NR

NR=Not Reported; N/A=Not Available; ↑Tg, hypertriglyceridemia; ↑Chol, hypercholesterolemia*:
Selected studies in HIV-positive populations were considered for: 1) published during the current decade, 2) represented diverse settings from Latin America, Europe and Africa, and 3) evaluated similar populations and variables.